BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Park WB, Kwon NJ, Choi SJ, Kang CK, Choe PG, Kim JY, Yun J, Lee GW, Seong MW, Kim NJ, Seo JS, Oh MD. Virus Isolation from the First Patient with SARS-CoV-2 in Korea. J Korean Med Sci 2020;35:e84. [PMID: 32080990 DOI: 10.3346/jkms.2020.35.e84] [Cited by in Crossref: 94] [Cited by in F6Publishing: 87] [Article Influence: 47.0] [Reference Citation Analysis]
Number Citing Articles
1 Charvet A, Bardin-monnier N, Thomas D, Dufaud O, Pfrimmer M, Barrault M, Bourrous S, Mocho V, Ouf F, Poirier S, Jeanmichel L, Segovia C, Ferry D, Grauby O. Impact of washing cycles on the performances of face masks. Journal of Aerosol Science 2022;160:105914. [DOI: 10.1016/j.jaerosci.2021.105914] [Reference Citation Analysis]
2 Hwang Y, Kim D, Ryu S. Decreased patient visits for ankle sprain during the COVID-19 pandemic in South Korea: A nationwide retrospective study. Preventive Medicine Reports 2022. [DOI: 10.1016/j.pmedr.2022.101728] [Reference Citation Analysis]
3 Barreto-Vieira DF, da Silva MAN, Garcia CC, Miranda MD, Matos ADR, Caetano BC, Resende PC, Motta FC, Siqueira MM, Girard-Dias W, Archanjo BS, Barth OM. Morphology and morphogenesis of SARS-CoV-2 in Vero-E6 cells. Mem Inst Oswaldo Cruz 2021;116:e200443. [PMID: 33566951 DOI: 10.1590/0074-02760200443] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Bar-On YM, Flamholz A, Phillips R, Milo R. SARS-CoV-2 (COVID-19) by the numbers. Elife 2020;9:e57309. [PMID: 32228860 DOI: 10.7554/eLife.57309] [Cited by in Crossref: 316] [Cited by in F6Publishing: 171] [Article Influence: 158.0] [Reference Citation Analysis]
5 Liu T, Chen Z, Chen W, Chen X, Hosseini M, Yang Z, Li J, Ho D, Turay D, Gheorghe CP, Jones W, Wang C. A benchmarking study of SARS-CoV-2 whole-genome sequencing protocols using COVID-19 patient samples. iScience 2021;24:102892. [PMID: 34308277 DOI: 10.1016/j.isci.2021.102892] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Lee HY, Ahn J, Park J, Kang CK, Won SH, Kim DW, Park JH, Chung KH, Joh JS, Bang JH, Kang CH, Oh MD, Pyun WB; Korean Society of Hypertension., National Committee for Clinical Management of Emerging Infectious Diseases. Different therapeutic associations of renin-angiotensin system inhibitors with coronavirus disease 2019 compared with usual pneumonia. Korean J Intern Med 2021;36:617-28. [PMID: 33858123 DOI: 10.3904/kjim.2020.656] [Reference Citation Analysis]
7 Pavel STI, Yetiskin H, Aydin G, Holyavkin C, Uygut MA, Dursun ZB, Celik İ, Cevik C, Ozdarendeli A. Isolation and characterization of severe acute respiratory syndrome coronavirus 2 in Turkey. PLoS One 2020;15:e0238614. [PMID: 32936826 DOI: 10.1371/journal.pone.0238614] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Fernández Muñoz B, Lopez-Navas L, Gonzalez Bermejo M, Lomas Romero IM, Montiel Aguilera MÁ, Campos Cuerva R, Arribas Arribas B, Nogueras S, Carmona Sánchez G, Santos González M. A PROPRIETARY GMP HUMAN PLATELET LYSATE FOR THE EXPANSION OF DERMAL FIBROBLASTS FOR CLINICAL APPLICATIONS. Platelets 2021;:1-12. [PMID: 33393414 DOI: 10.1080/09537104.2020.1856356] [Reference Citation Analysis]
9 Kulkarni PG, Sakharkar A, Banerjee T. Understanding the role of nACE2 in neurogenic hypertension among COVID-19 patients. Hypertens Res 2021. [PMID: 34848886 DOI: 10.1038/s41440-021-00800-4] [Reference Citation Analysis]
10 Najafi Fard S, Petrone L, Petruccioli E, Alonzi T, Matusali G, Colavita F, Castilletti C, Capobianchi MR, Goletti D. In Vitro Models for Studying Entry, Tissue Tropism, and Therapeutic Approaches of Highly Pathogenic Coronaviruses. Biomed Res Int 2021;2021:8856018. [PMID: 34239932 DOI: 10.1155/2021/8856018] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Rosa RB, Dantas WM, do Nascimento JCF, da Silva MV, de Oliveira RN, Pena LJ. In Vitro and In Vivo Models for Studying SARS-CoV-2, the Etiological Agent Responsible for COVID-19 Pandemic. Viruses 2021;13:379. [PMID: 33673614 DOI: 10.3390/v13030379] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
12 Park J, Chung E. Learning from past pandemic governance: Early response and Public-Private Partnerships in testing of COVID-19 in South Korea. World Dev 2021;137:105198. [PMID: 32982017 DOI: 10.1016/j.worlddev.2020.105198] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 6.5] [Reference Citation Analysis]
13 Araujo DB, Machado RRG, Amgarten DE, Malta FM, de Araujo GG, Monteiro CO, Candido ED, Soares CP, de Menezes FG, Pires ACC, Santana RAF, Viana AO, Dorlass E, Thomazelli L, Ferreira LCS, Botosso VF, Carvalho CRG, Oliveira DBL, Pinho JRR, Durigon EL. SARS-CoV-2 isolation from the first reported patients in Brazil and establishment of a coordinated task network. Mem Inst Oswaldo Cruz 2020;115:e200342. [PMID: 33111751 DOI: 10.1590/0074-02760200342] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 12.0] [Reference Citation Analysis]
14 Varbanov M, Bertrand I, Philippot S, Retourney C, Gardette M, Hartard C, Jeulin H, Duval RE, Loret JF, Schvoerer E, Gantzer C. Somatic coliphages are conservative indicators of SARS-CoV-2 inactivation during heat and alkaline pH treatments. Sci Total Environ 2021;797:149112. [PMID: 34346352 DOI: 10.1016/j.scitotenv.2021.149112] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Napolitano F, Xu X, Gao X. Impact of computational approaches in the fight against COVID-19: an AI guided review of 17 000 studies. Brief Bioinform 2021:bbab456. [PMID: 34788381 DOI: 10.1093/bib/bbab456] [Reference Citation Analysis]
16 Lee KY, Rhim JW, Kang JH. Immunopathogenesis of COVID-19 and early immunomodulators. Clin Exp Pediatr 2020;63:239-50. [PMID: 32664709 DOI: 10.3345/cep.2020.00759] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 9.5] [Reference Citation Analysis]
17 Mercola J, Grant WB, Wagner CL. Evidence Regarding Vitamin D and Risk of COVID-19 and Its Severity. Nutrients 2020;12:E3361. [PMID: 33142828 DOI: 10.3390/nu12113361] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 20.5] [Reference Citation Analysis]
18 Hasöksüz M, Kiliç S, Saraç F. Coronaviruses and SARS-COV-2. Turk J Med Sci 2020;50:549-56. [PMID: 32293832 DOI: 10.3906/sag-2004-127] [Cited by in Crossref: 68] [Cited by in F6Publishing: 1] [Article Influence: 34.0] [Reference Citation Analysis]
19 Kumar R, Rathi H, Haq A, Wimalawansa SJ, Sharma A. Putative roles of vitamin D in modulating immune response and immunopathology associated with COVID-19. Virus Res 2021;292:198235. [PMID: 33232783 DOI: 10.1016/j.virusres.2020.198235] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
20 Lee BU. Minimum Sizes of Respiratory Particles Carrying SARS-CoV-2 and the Possibility of Aerosol Generation. Int J Environ Res Public Health 2020;17:E6960. [PMID: 32977575 DOI: 10.3390/ijerph17196960] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
21 Lega S, Naviglio S, Volpi S, Tommasini A. Recent Insight into SARS-CoV2 Immunopathology and Rationale for Potential Treatment and Preventive Strategies in COVID-19. Vaccines (Basel) 2020;8:E224. [PMID: 32423059 DOI: 10.3390/vaccines8020224] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 14.0] [Reference Citation Analysis]
22 Rantam FA, Prakoeswa CRS, Tinduh D, Nugraha J, Susilowati H, Wijaya AY, Puspaningsih NNT, Puspitasari D, Husada D, Kurniati ND, Aryati A. Characterization of SARS-CoV-2 East Java isolate, Indonesia. F1000Res 2021;10:480. [PMID: 34621509 DOI: 10.12688/f1000research.53137.1] [Reference Citation Analysis]
23 Sadhukhan P, Ugurlu MT, Hoque MO. Effect of COVID-19 on Lungs: Focusing on Prospective Malignant Phenotypes. Cancers (Basel) 2020;12:E3822. [PMID: 33352869 DOI: 10.3390/cancers12123822] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
24 Wang J, Feng H, Zhang S, Ni Z, Ni L, Chen Y, Zhuo L, Zhong Z, Qu T. SARS-CoV-2 RNA detection of hospital isolation wards hygiene monitoring during the Coronavirus Disease 2019 outbreak in a Chinese hospital. Int J Infect Dis 2020;94:103-6. [PMID: 32311449 DOI: 10.1016/j.ijid.2020.04.024] [Cited by in Crossref: 122] [Cited by in F6Publishing: 103] [Article Influence: 61.0] [Reference Citation Analysis]
25 Dulskas A, Klimovskij M, Senkus L, Samalavicius NE. Comment on: Disposable customized aerosol containment chamber for oral cancer biopsy: A novel technique during COVID-19 pandemic. J Surg Oncol 2020;122:992-3. [PMID: 32617985 DOI: 10.1002/jso.26083] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Sarfraz A, Hasan Siddiqui S, Iqbal J, Ali SA, Hasan Z, Sarfraz Z, Iqbal NT. COVID-19 age-dependent immunology and clinical outcomes: implications for vaccines. J Dev Orig Health Dis 2021;:1-7. [PMID: 34284839 DOI: 10.1017/S2040174421000398] [Reference Citation Analysis]
27 Li D, Zhang J, Li J. Primer design for quantitative real-time PCR for the emerging Coronavirus SARS-CoV-2. Theranostics 2020;10:7150-62. [PMID: 32641984 DOI: 10.7150/thno.47649] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 15.0] [Reference Citation Analysis]
28 Kogan EA, Berezovsky YS, Protsenko DD, Bagdasaryan TR, Gretsov EM, Demura SA, Demyashkin GA, Kalinin DV, Kukleva AD, Kurilina EV, Nekrasova TP, Paramonova NB, Ponomarev AB, Radenska-lopovok SG, Semyonova LA, Tertychny AS. PATHOLOGICAL ANATOMY OF INFECTION CAUSED BY SARS-COV-2. Sud med (Online) 2020;6:8-30. [DOI: 10.19048/2411-8729-2020-6-2-8-30] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 6.5] [Reference Citation Analysis]
29 Cantera JL, Cate DM, Golden A, Peck RB, Lillis LL, Domingo GJ, Murphy E, Barnhart BC, Anderson CA, Alonzo LF, Glukhova V, Hermansky G, Barrios-Lopez B, Spencer E, Kuhn S, Islam Z, Grant BD, Kraft L, Herve K, de Puyraimond V, Hwang Y, Dewan PK, Weigl BH, Nichols KP, Boyle DS. Screening Antibodies Raised against the Spike Glycoprotein of SARS-CoV-2 to Support the Development of Rapid Antigen Assays. ACS Omega 2021;6:20139-48. [PMID: 34373846 DOI: 10.1021/acsomega.1c01321] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Mautner L, Baillie CK, Herold HM, Volkwein W, Guertler P, Eberle U, Ackermann N, Sing A, Pavlovic M, Goerlich O, Busch U, Wassill L, Huber I, Baiker A. Rapid point-of-care detection of SARS-CoV-2 using reverse transcription loop-mediated isothermal amplification (RT-LAMP). Virol J 2020;17:160. [PMID: 33087160 DOI: 10.1186/s12985-020-01435-6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 11.5] [Reference Citation Analysis]
31 Vuorinen V, Aarnio M, Alava M, Alopaeus V, Atanasova N, Auvinen M, Balasubramanian N, Bordbar H, Erästö P, Grande R, Hayward N, Hellsten A, Hostikka S, Hokkanen J, Kaario O, Karvinen A, Kivistö I, Korhonen M, Kosonen R, Kuusela J, Lestinen S, Laurila E, Nieminen HJ, Peltonen P, Pokki J, Puisto A, Råback P, Salmenjoki H, Sironen T, Österberg M. Modelling aerosol transport and virus exposure with numerical simulations in relation to SARS-CoV-2 transmission by inhalation indoors. Saf Sci 2020;130:104866. [PMID: 32834511 DOI: 10.1016/j.ssci.2020.104866] [Cited by in Crossref: 123] [Cited by in F6Publishing: 66] [Article Influence: 61.5] [Reference Citation Analysis]
32 Sagris D, Papanikolaou A, Kvernland A, Korompoki E, Frontera JA, Troxel AB, Gavriatopoulou M, Milionis H, Lip GYH, Michel P, Yaghi S, Ntaios G. COVID-19 and ischemic stroke. Eur J Neurol 2021. [PMID: 34224187 DOI: 10.1111/ene.15008] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Caldas LA, Carneiro FA, Monteiro FL, Augusto I, Higa LM, Miranda K, Tanuri A, de Souza W. Intracellular host cell membrane remodelling induced by SARS-CoV-2 infection in vitro. Biol Cell 2021;113:281-93. [PMID: 33600624 DOI: 10.1111/boc.202000146] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Adugna DG. Current Clinical Application of Mesenchymal Stem Cells in the Treatment of Severe COVID-19 Patients: Review. Stem Cells Cloning 2021;14:71-80. [PMID: 34785907 DOI: 10.2147/SCCAA.S333800] [Reference Citation Analysis]
35 Chee J, Loh WS, Liu Z, Mullol J, Wang Y. Clinical-Pathological Correlation of the Pathophysiology and Mechanism of Action of COVID-19 - a Primer for Clinicians. Curr Allergy Asthma Rep 2021;21:38. [PMID: 34259961 DOI: 10.1007/s11882-021-01015-w] [Reference Citation Analysis]
36 Falzone L, Gattuso G, Tsatsakis A, Spandidos DA, Libra M. Current and innovative methods for the diagnosis of COVID‑19 infection (Review). Int J Mol Med 2021;47:100. [PMID: 33846767 DOI: 10.3892/ijmm.2021.4933] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
37 Zeng Z, Xu L, Xie XY, Yan HL, Xie BJ, Xu WZ, Liu XA, Kang GJ, Jiang WL, Yuan JP. Pulmonary pathology of early-phase COVID-19 pneumonia in a patient with a benign lung lesion. Histopathology. 2020;77:823-831. [PMID: 32374419 DOI: 10.1111/his.14138] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 23.5] [Reference Citation Analysis]
38 Tay MZ, Poh CM, Rénia L, MacAry PA, Ng LFP. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol 2020;20:363-74. [PMID: 32346093 DOI: 10.1038/s41577-020-0311-8] [Cited by in Crossref: 1506] [Cited by in F6Publishing: 1403] [Article Influence: 753.0] [Reference Citation Analysis]
39 Chong ZX, Liew WPP, Ong HK, Yong CY, Shit CS, Ho WY, Ng SYL, Yeap SK. Current diagnostic approaches to detect two important betacoronaviruses: Middle East respiratory syndrome coronavirus (MERS-CoV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Pathol Res Pract 2021;225:153565. [PMID: 34333398 DOI: 10.1016/j.prp.2021.153565] [Reference Citation Analysis]
40 Dolati-Somarin A, Abd-Nikfarjam B. The Reasons for Higher Mortality Rate in Opium Addicted Patients with COVID-19: A Narrative Review. Iran J Public Health 2021;50:470-9. [PMID: 34178794 DOI: 10.18502/ijph.v50i3.5587] [Reference Citation Analysis]
41 Abdullah SF, Sharquie IK. SARS-CoV-2: A Piece of Bad News. Medeni Med J 2020;35:151-60. [PMID: 32733765 DOI: 10.5222/MMJ.2020.82584] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Talukder ME, Alam F, Pervez MN, Jiangming W, Hassan F, Stylios GK, Naddeo V, Song H. New generation washable PES membrane face mask for virus filtration. Nanocomposites 2022;8:13-23. [DOI: 10.1080/20550324.2021.2008209] [Reference Citation Analysis]
43 Kim JM, Yoo JH, Cho HK, Hong ST. Analysis of PubMed and KoreaMed Indexed Korean Publications on COVID-19. J Korean Med Sci 2021;36:e345. [PMID: 34931501 DOI: 10.3346/jkms.2021.36.e345] [Reference Citation Analysis]
44 Schönrich G, Raftery MJ, Samstag Y. Devilishly radical NETwork in COVID-19: Oxidative stress, neutrophil extracellular traps (NETs), and T cell suppression. Adv Biol Regul 2020;77:100741. [PMID: 32773102 DOI: 10.1016/j.jbior.2020.100741] [Cited by in Crossref: 63] [Cited by in F6Publishing: 62] [Article Influence: 31.5] [Reference Citation Analysis]
45 Kim JK, Ryu SW, Kim JS, Jung BK. Performance evaluation of four rapid antibody tests for the detection of severe acute respiratory syndrome coronavirus 2. J Clin Lab Anal 2022;:e24374. [PMID: 35446996 DOI: 10.1002/jcla.24374] [Reference Citation Analysis]
46 Choe PG, Kang CK, Suh HJ, Jung J, Kang E, Lee SY, Song K, Kim HB, Kim NJ, Park WB, Kim ES, Oh M. Antibody Responses to SARS-CoV-2 at 8 Weeks Postinfection in Asymptomatic Patients. Emerg Infect Dis 2020;26. [DOI: 10.3201/eid2610.20211] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
47 Duś-Ilnicka I, Szymczak A, Małodobra-Mazur M, Tokarski M. Role of Laboratory Medicine in SARS-CoV-2 Diagnostics. Lessons Learned from a Pandemic. Healthcare (Basel) 2021;9:915. [PMID: 34356292 DOI: 10.3390/healthcare9070915] [Reference Citation Analysis]
48 Manenti A, Maggetti M, Casa E, Martinuzzi D, Torelli A, Trombetta CM, Marchi S, Montomoli E. Evaluation of SARS-CoV-2 neutralizing antibodies using a CPE-based colorimetric live virus micro-neutralization assay in human serum samples. J Med Virol 2020;92:2096-104. [PMID: 32383254 DOI: 10.1002/jmv.25986] [Cited by in Crossref: 54] [Cited by in F6Publishing: 42] [Article Influence: 27.0] [Reference Citation Analysis]
49 Al-Hadyan K, Alsbeih G, Nobah A, Lindstrom J, Falatah S, Faran N, Al-Ghamdi S, Moftah B, Alhmaid R. In-House Filtration Efficiency Assessment of Vapor Hydrogen Peroxide Decontaminated Filtering Facepiece Respirators (FFRs). Int J Environ Res Public Health 2021;18:7169. [PMID: 34281105 DOI: 10.3390/ijerph18137169] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
50 Sonnleitner ST, Prelog M, Jansen B, Rodgarkia-Dara C, Gietl S, Schönegger CM, Koblmüller S, Sturmbauer C, Posch W, Almanzar G, Jury H, Loney T, Tichy A, Nowotny N, Walder G. Maintenance of neutralizing antibodies over ten months in convalescent SARS-CoV-2 afflicted patients. Transbound Emerg Dis 2021. [PMID: 33960696 DOI: 10.1111/tbed.14130] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
51 Akter F, Araf Y, Hosen MJ. Corticosteroids for COVID-19: worth it or not? Mol Biol Rep 2021. [PMID: 34643927 DOI: 10.1007/s11033-021-06793-0] [Reference Citation Analysis]
52 Akbari A, Rezaie J. Potential therapeutic application of mesenchymal stem cell-derived exosomes in SARS-CoV-2 pneumonia. Stem Cell Res Ther 2020;11:356. [PMID: 32795359 DOI: 10.1186/s13287-020-01866-6] [Cited by in Crossref: 30] [Cited by in F6Publishing: 35] [Article Influence: 15.0] [Reference Citation Analysis]
53 Barreto HG, de Pádua Milagres FA, de Araújo GC, Daúde MM, Benedito VA. Diagnosing the novel SARS-CoV-2 by quantitative RT-PCR: variations and opportunities. J Mol Med (Berl) 2020;98:1727-36. [PMID: 33067676 DOI: 10.1007/s00109-020-01992-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
54 Sakharov AS, Zhukov K. Study of an Air Curtain in the Context of Individual Protection from Exposure to Coronavirus (SARS-CoV-2) Contained in Cough-Generated Fluid Particles. Physics 2020;2:340-51. [DOI: 10.3390/physics2030018] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
55 Espinoza EPS, Cortes MF, Noguera SV, Paula AV, Guimarães T, Boas LSV, Park M, Silva CCD, Morales I, Perdigão Neto LV, Tozetto-Mendoza TR, Boszczowski I, Sabino EC, Mendes-Correa MC, Levin AS, Costa SF. Are mobile phones part of the chain of transmission of SARS-CoV-2 in hospital settings? Rev Inst Med Trop Sao Paulo 2021;63:e74. [PMID: 34586308 DOI: 10.1590/S1678-9946202163074] [Reference Citation Analysis]
56 Mahmood Z, Alrefai H, Hetta HF, A. Kader H, Munawar N, Abdul Rahman S, Elshaer S, Batiha GE, Muhammad K. Investigating Virological, Immunological, and Pathological Avenues to Identify Potential Targets for Developing COVID-19 Treatment and Prevention Strategies. Vaccines 2020;8:443. [DOI: 10.3390/vaccines8030443] [Reference Citation Analysis]
57 Wurtz N, Penant G, Jardot P, Duclos N, La Scola B. Culture of SARS-CoV-2 in a panel of laboratory cell lines, permissivity, and differences in growth profile. Eur J Clin Microbiol Infect Dis 2021;40:477-84. [PMID: 33389257 DOI: 10.1007/s10096-020-04106-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 10.0] [Reference Citation Analysis]
58 Hojyo S, Uchida M, Tanaka K, Hasebe R, Tanaka Y, Murakami M, Hirano T. How COVID-19 induces cytokine storm with high mortality. Inflamm Regen 2020;40:37. [PMID: 33014208 DOI: 10.1186/s41232-020-00146-3] [Cited by in Crossref: 190] [Cited by in F6Publishing: 1] [Article Influence: 95.0] [Reference Citation Analysis]
59 Sayan M, Sarigul Yildirim F, Sanlidag T, Uzun B, Uzun Ozsahin D, Ozsahin I. Capacity Evaluation of Diagnostic Tests For COVID-19 Using Multicriteria Decision-Making Techniques. Comput Math Methods Med 2020;2020:1560250. [PMID: 32802146 DOI: 10.1155/2020/1560250] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
60 Farkash EA, Wilson AM, Jentzen JM. Authors' Reply. J Am Soc Nephrol 2020;31:2225-6. [PMID: 32792369 DOI: 10.1681/ASN.2020060847] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
61 Choe PG, Kang CK, Suh HJ, Jung J, Song KH, Bang JH, Kim ES, Kim HB, Park SW, Kim NJ, Park WB, Oh MD. Waning Antibody Responses in Asymptomatic and Symptomatic SARS-CoV-2 Infection. Emerg Infect Dis 2021;27. [PMID: 33050983 DOI: 10.3201/eid2701.203515] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 19.0] [Reference Citation Analysis]
62 Wu SY, Yau HS, Yu MY, Tsang HF, Chan LWC, Cho WCS, Shing Yu AC, Yuen Yim AK, Li MJW, Wong YKE, Pei XM, Cesar Wong SC. The diagnostic methods in the COVID-19 pandemic, today and in the future. Expert Rev Mol Diagn 2020;20:985-93. [PMID: 32845192 DOI: 10.1080/14737159.2020.1816171] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
63 Karonova TL, Andreeva AT, Golovatuk KA, Bykova ES, Simanenkova AV, Vashukova MA, Grant WB, Shlyakhto EV. Low 25(OH)D Level Is Associated with Severe Course and Poor Prognosis in COVID-19. Nutrients 2021;13:3021. [PMID: 34578898 DOI: 10.3390/nu13093021] [Reference Citation Analysis]
64 Riva L, Yuan S, Yin X, Martin-Sancho L, Matsunaga N, Burgstaller-Muehlbacher S, Pache L, De Jesus PP, Hull MV, Chang M, Chan JF, Cao J, Poon VK, Herbert K, Nguyen TT, Pu Y, Nguyen C, Rubanov A, Martinez-Sobrido L, Liu WC, Miorin L, White KM, Johnson JR, Benner C, Sun R, Schultz PG, Su A, Garcia-Sastre A, Chatterjee AK, Yuen KY, Chanda SK. A Large-scale Drug Repositioning Survey for SARS-CoV-2 Antivirals. bioRxiv 2020:2020. [PMID: 32511357 DOI: 10.1101/2020.04.16.044016] [Cited by in Crossref: 31] [Cited by in F6Publishing: 5] [Article Influence: 15.5] [Reference Citation Analysis]
65 Kang CK, Seong MW, Choi SJ, Kim TS, Choe PG, Song SH, Kim NJ, Park WB, Oh MD. In vitro activity of lopinavir/ritonavir and hydroxychloroquine against severe acute respiratory syndrome coronavirus 2 at concentrations achievable by usual doses. Korean J Intern Med 2020;35:782-7. [PMID: 32460458 DOI: 10.3904/kjim.2020.157] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 14.5] [Reference Citation Analysis]
66 Borges do Nascimento IJ, Cacic N, Abdulazeem HM, von Groote TC, Jayarajah U, Weerasekara I, Esfahani MA, Civile VT, Marusic A, Jeroncic A, Carvas Junior N, Pericic TP, Zakarija-Grkovic I, Meirelles Guimarães SM, Luigi Bragazzi N, Bjorklund M, Sofi-Mahmudi A, Altujjar M, Tian M, Arcani DMC, O'Mathúna DP, Marcolino MS. Novel Coronavirus Infection (COVID-19) in Humans: A Scoping Review and Meta-Analysis. J Clin Med 2020;9:E941. [PMID: 32235486 DOI: 10.3390/jcm9040941] [Cited by in Crossref: 203] [Cited by in F6Publishing: 192] [Article Influence: 101.5] [Reference Citation Analysis]
67 Baselga M, Güemes A, Alba JJ, Schuhmacher AJ. SARS-CoV-2 Droplet and Airborne Transmission Heterogeneity. JCM 2022;11:2607. [DOI: 10.3390/jcm11092607] [Reference Citation Analysis]
68 Faried A, Dian S, Halim D, Hermanto Y, Pratama DMA, Arifin MZ. The neurological significance of COVID-19: Lesson learn from the pandemic. Interdiscip Neurosurg 2020;22:100809. [PMID: 33520665 DOI: 10.1016/j.inat.2020.100809] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
69 Wu H, Fujioka Y, Sakaguchi S, Suzuki Y, Nakano T. Three-dimensional reconstruction by electron tomography for the application to ultrastructural analysis of SARS-CoV-2 particles. Med Mol Morphol 2021. [PMID: 34825978 DOI: 10.1007/s00795-021-00309-2] [Reference Citation Analysis]
70 Grenga L, Gallais F, Pible O, Gaillard JC, Gouveia D, Batina H, Bazaline N, Ruat S, Culotta K, Miotello G, Debroas S, Roncato MA, Steinmetz G, Foissard C, Desplan A, Alpha-Bazin B, Almunia C, Gas F, Bellanger L, Armengaud J. Shotgun proteomics analysis of SARS-CoV-2-infected cells and how it can optimize whole viral particle antigen production for vaccines. Emerg Microbes Infect 2020;9:1712-21. [PMID: 32619390 DOI: 10.1080/22221751.2020.1791737] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 16.0] [Reference Citation Analysis]
71 Golchin A, Seyedjafari E, Ardeshirylajimi A. Mesenchymal stem cell therapy for covid-19: Present or future. Stem Cell Rev Rep. 2020;16:427-433. [PMID: 32281052 DOI: 10.1007/s12015-020-09973-w] [Cited by in Crossref: 127] [Cited by in F6Publishing: 124] [Article Influence: 63.5] [Reference Citation Analysis]
72 Won J, Lee S, Park M, Kim TY, Park MG, Choi BY, Kim D, Chang H, Kim VN, Lee CJ. Development of a Laboratory-safe and Low-cost Detection Protocol for SARS-CoV-2 of the Coronavirus Disease 2019 (COVID-19). Exp Neurobiol 2020;29:107-19. [PMID: 32156101 DOI: 10.5607/en20009] [Cited by in Crossref: 89] [Cited by in F6Publishing: 81] [Article Influence: 44.5] [Reference Citation Analysis]
73 Tarnawski AS, Ahluwalia A. Endothelial cells and blood vessels are major targets for COVID-19-induced tissue injury and spreading to various organs. World J Gastroenterol 2022;28:275-89. [PMID: 35110950 DOI: 10.3748/wjg.v28.i3.275] [Reference Citation Analysis]
74 Díaz FJ, Aguilar-Jiménez W, Flórez-Álvarez L, Valencia G, Laiton-Donato K, Franco-Muñoz C, Álvarez-Díaz D, Mercado-Reyes M, Rugeles MT. Isolation and characterization of an early SARS-CoV-2 isolate from the 2020 epidemic in Medellín, Colombia. Biomedica 2020;40:148-58. [PMID: 33152198 DOI: 10.7705/biomedica.5834] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
75 Chattopadhyay P, Srinivasa Vasudevan J, Pandey R. Noncoding RNAs: modulators and modulatable players during infection-induced stress response. Brief Funct Genomics 2021;20:28-41. [PMID: 33491070 DOI: 10.1093/bfgp/elaa026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
76 Mondal R, Lahiri D, Deb S, Bandyopadhyay D, Shome G, Sarkar S, Paria SR, Thakurta TG, Singla P, Biswas SC. COVID-19: Are we dealing with a multisystem vasculopathy in disguise of a viral infection? J Thromb Thrombolysis 2020;50:567-79. [PMID: 32627126 DOI: 10.1007/s11239-020-02210-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
77 Falcone C, Caracciolo M, Correale P, Macheda S, Vadalà EG, La Scala S, Tescione M, Danieli R, Ferrarelli A, Tarsitano MG, Romano L, De Lorenzo A. Can Adenosine Fight COVID-19 Acute Respiratory Distress Syndrome? J Clin Med 2020;9:E3045. [PMID: 32967358 DOI: 10.3390/jcm9093045] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
78 Lee HY, Ahn J, Park J, Kyung Kang C, Won SH, Wook Kim D, Park JH, Chung KH, Joh JS, Bang JH, Hee Kang C, Bum Pyun W, Oh MD; Korean Society of Hypertension, National Committee for Clinical Management of Emerging Infectious Diseases. Beneficial Effect of Statins in COVID-19-Related Outcomes-Brief Report: A National Population-Based Cohort Study. Arterioscler Thromb Vasc Biol 2021;41:e175-82. [PMID: 33535790 DOI: 10.1161/ATVBAHA.120.315551] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
79 Whiley H, Keerthirathne TP, Nisar MA, White MAF, Ross KE. Viral Filtration Efficiency of Fabric Masks Compared with Surgical and N95 Masks. Pathogens 2020;9:E762. [PMID: 32957638 DOI: 10.3390/pathogens9090762] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
80 Choe PG, Kang CK, Suh HJ, Jung J, Kang E, Lee SY, Song KH, Kim HB, Kim NJ, Park WB, Kim ES, Oh MD. Antibody Responses to SARS-CoV-2 at 8 Weeks Postinfection in Asymptomatic Patients. Emerg Infect Dis 2020;26:2484-7. [PMID: 32579877 DOI: 10.3201/eid2610.202211] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 19.0] [Reference Citation Analysis]
81 Bielińska-Wąż D, Wąż P. Non-standard bioinformatics characterization of SARS-CoV-2. Comput Biol Med 2021;131:104247. [PMID: 33611129 DOI: 10.1016/j.compbiomed.2021.104247] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
82 Harenberg J, Favaloro E. COVID-19: progression of disease and intravascular coagulation - present status and future perspectives. Clin Chem Lab Med 2020;58:1029-36. [PMID: 32406381 DOI: 10.1515/cclm-2020-0502] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 20.0] [Reference Citation Analysis]
83 Alquisiras-Burgos I, Peralta-Arrieta I, Alonso-Palomares LA, Zacapala-Gómez AE, Salmerón-Bárcenas EG, Aguilera P. Neurological Complications Associated with the Blood-Brain Barrier Damage Induced by the Inflammatory Response During SARS-CoV-2 Infection. Mol Neurobiol 2021;58:520-35. [PMID: 32978729 DOI: 10.1007/s12035-020-02134-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
84 Wang R, Luo X, Liu F, Luo S. Confronting the threat of SARS-CoV-2: Realities, challenges and therapeutic strategies (Review). Exp Ther Med 2021;21:155. [PMID: 33456522 DOI: 10.3892/etm.2020.9587] [Reference Citation Analysis]
85 Kim SI, Noh J, Kim S, Choi Y, Yoo DK, Lee Y, Lee H, Jung J, Kang CK, Song KH, Choe PG, Kim HB, Kim ES, Kim NJ, Seong MW, Park WB, Oh MD, Kwon S, Chung J. Stereotypic neutralizing VH antibodies against SARS-CoV-2 spike protein receptor binding domain in patients with COVID-19 and healthy individuals. Sci Transl Med 2021;13:eabd6990. [PMID: 33397677 DOI: 10.1126/scitranslmed.abd6990] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 15.0] [Reference Citation Analysis]
86 Kim HY, Lee JH, Kim MJ, Park SC, Choi M, Lee W, Ku KB, Kim BT, Changkyun Park E, Kim HG, Kim SI. Development of a SARS-CoV-2-specific biosensor for antigen detection using scFv-Fc fusion proteins. Biosens Bioelectron 2021;175:112868. [PMID: 33281048 DOI: 10.1016/j.bios.2020.112868] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
87 Walker EM, Jasper AE, Davis L, Yip KP, Faniyi AA, Hughes MJ, Crisford HA, Spittle DA, Sapey E, Belchamber KBR, Scott A. Mitigating Health Risks to Reopen a Clinical Research Laboratory During the COVID-19 Pandemic: A Framework. JMIR Res Protoc 2020;9:e22570. [PMID: 33146625 DOI: 10.2196/22570] [Reference Citation Analysis]
88 Yan Y, Wu K, Chen J, Liu H, Huang Y, Zhang Y, Xiong J, Quan W, Wu X, Liang Y, He K, Jia Z, Wang D, Liu D, Wei H, Chen J. Rapid Acquisition of High-Quality SARS-CoV-2 Genome via Amplicon-Oxford Nanopore Sequencing. Virol Sin 2021. [PMID: 33851337 DOI: 10.1007/s12250-021-00378-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
89 Masood KI, Yameen M, Ashraf J, Shahid S, Mahmood SF, Nasir A, Nasir N, Jamil B, Ghanchi NK, Khanum I, Razzak SA, Kanji A, Hussain R, E Rottenberg M, Hasan Z. Upregulated type I interferon responses in asymptomatic COVID-19 infection are associated with improved clinical outcome. Sci Rep 2021;11:22958. [PMID: 34824360 DOI: 10.1038/s41598-021-02489-4] [Reference Citation Analysis]
90 Kumar S, Nyodu R, Maurya VK, Saxena SK. Morphology, Genome Organization, Replication, and Pathogenesis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). In: Saxena SK, editor. Coronavirus Disease 2019 (COVID-19). Singapore: Springer; 2020. pp. 23-31. [DOI: 10.1007/978-981-15-4814-7_3] [Cited by in Crossref: 42] [Cited by in F6Publishing: 13] [Article Influence: 21.0] [Reference Citation Analysis]
91 da Silva SJR, Silva CTAD, Guarines KM, Mendes RPG, Pardee K, Kohl A, Pena L. Clinical and Laboratory Diagnosis of SARS-CoV-2, the Virus Causing COVID-19. ACS Infect Dis 2020;6:2319-36. [PMID: 32786280 DOI: 10.1021/acsinfecdis.0c00274] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 10.0] [Reference Citation Analysis]
92 Hopfer H, Herzig MC, Gosert R, Menter T, Hench J, Tzankov A, Hirsch HH, Miller SE. Hunting coronavirus by transmission electron microscopy - a guide to SARS-CoV-2-associated ultrastructural pathology in COVID-19 tissues. Histopathology 2021;78:358-70. [PMID: 32981112 DOI: 10.1111/his.14264] [Cited by in Crossref: 23] [Cited by in F6Publishing: 31] [Article Influence: 11.5] [Reference Citation Analysis]
93 Hojyo S, Uchida M, Tanaka K, Hasebe R, Tanaka Y, Murakami M, Hirano T. How COVID-19 induces cytokine storm with high mortality. Inflamm Regen 2020;40:37. [PMID: 33014208 DOI: 10.1186/s41232-020-00146-3] [Cited by in Crossref: 94] [Cited by in F6Publishing: 101] [Article Influence: 47.0] [Reference Citation Analysis]
94 Zhang G, Zhang J, Wang B, Zhu X, Wang Q, Qiu S. Analysis of clinical characteristics and laboratory findings of 95 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a retrospective analysis. Respir Res. 2020;21:74. [PMID: 32216803 DOI: 10.1186/s12931-020-01338-8] [Cited by in Crossref: 131] [Cited by in F6Publishing: 123] [Article Influence: 65.5] [Reference Citation Analysis]
95 Park M, Won J, Choi BY, Lee CJ. Optimization of primer sets and detection protocols for SARS-CoV-2 of coronavirus disease 2019 (COVID-19) using PCR and real-time PCR. Exp Mol Med 2020;52:963-77. [PMID: 32546849 DOI: 10.1038/s12276-020-0452-7] [Cited by in Crossref: 41] [Cited by in F6Publishing: 28] [Article Influence: 20.5] [Reference Citation Analysis]
96 Barreto-vieira DF, da Silva MAN, de Almeida ALT, Rasinhas ADC, Monteiro ME, Miranda MD, Motta FC, Siqueira MM, Girard-dias W, Archanjo BS, Bozza PT, L. Souza TM, Gomes Dias SS, Soares VC, Barth OM. SARS-CoV-2: Ultrastructural Characterization of Morphogenesis in an In Vitro System. Viruses 2022;14:201. [DOI: 10.3390/v14020201] [Reference Citation Analysis]
97 Ben-Zuk N, Dechtman ID, Henn I, Weiss L, Afriat A, Krasner E, Gal Y. Potential Prophylactic Treatments for COVID-19. Viruses 2021;13:1292. [PMID: 34372498 DOI: 10.3390/v13071292] [Reference Citation Analysis]
98 Karamese M, Ozgur D, Tutuncu EE. Molecular characterization, phylogenetic and variation analyses of SARS-CoV-2 strains in Turkey. Future Microbiol 2021;16:1209-14. [PMID: 34615381 DOI: 10.2217/fmb-2021-0118] [Reference Citation Analysis]
99 Mcmillan CLD, Azuar A, Choo JJY, Modhiran N, Amarilla AA, Isaacs A, Honeyman KE, Cheung STM, Liang B, Wurm MJ, Pino P, Kint J, Fernando GJP, Landsberg MJ, Khromykh AA, Hobson-peters J, Watterson D, Young PR, Muller DA. Dermal Delivery of a SARS-CoV-2 Subunit Vaccine Induces Immunogenicity against Variants of Concern. Vaccines 2022;10:578. [DOI: 10.3390/vaccines10040578] [Reference Citation Analysis]
100 Lucaciu O, Aghiorghiesei O, Petrescu NB, Mirica IC, Benea HRC, Apostu D. In quest of a new therapeutic approach in COVID-19: the endocannabinoid system. Drug Metab Rev 2021;:1-13. [PMID: 33683968 DOI: 10.1080/03602532.2021.1895204] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
101 Laue M, Kauter A, Hoffmann T, Möller L, Michel J, Nitsche A. Morphometry of SARS-CoV and SARS-CoV-2 particles in ultrathin plastic sections of infected Vero cell cultures. Sci Rep 2021;11:3515. [PMID: 33568700 DOI: 10.1038/s41598-021-82852-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
102 Mese K, Bunz O, Volkwein W, Vemulapalli SPB, Zhang W, Schellhorn S, Heenemann K, Rueckner A, Sing A, Vahlenkamp TW, Severing AL, Gao J, Aydin M, Jung D, Bachmann HS, Zänker KS, Busch U, Baiker A, Griesinger C, Ehrhardt A. Enhanced Antiviral Function of Magnesium Chloride-Modified Heparin on a Broad Spectrum of Viruses. Int J Mol Sci 2021;22:10075. [PMID: 34576237 DOI: 10.3390/ijms221810075] [Reference Citation Analysis]
103 Mahmood Z, Alrefai H, Hetta HF, A Kader H, Munawar N, Abdul Rahman S, Elshaer S, Batiha GE, Muhammad K. Investigating Virological, Immunological, and Pathological Avenues to Identify Potential Targets for Developing COVID-19 Treatment and Prevention Strategies. Vaccines (Basel) 2020;8:E443. [PMID: 32781571 DOI: 10.3390/vaccines8030443] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
104 Hasöksüz M, Kiliç S, Saraç F. Coronaviruses and SARS-COV-2. Turk J Med Sci 2020;50:549-56. [PMID: 32293832 DOI: 10.3906/sag-2004-127] [Cited by in Crossref: 52] [Cited by in F6Publishing: 41] [Article Influence: 26.0] [Reference Citation Analysis]
105 Rivera-Izquierdo M, Valero-Ubierna MDC, Martínez-Diz S, Fernández-García MÁ, Martín-Romero DT, Maldonado-Rodríguez F, Sánchez-Pérez MR, Martín-delosReyes LM, Martínez-Ruiz V, Lardelli-Claret P, Jiménez-Mejías E. Clinical Factors, Preventive Behaviours and Temporal Outcomes Associated with COVID-19 Infection in Health Professionals at a Spanish Hospital. Int J Environ Res Public Health 2020;17:E4305. [PMID: 32560180 DOI: 10.3390/ijerph17124305] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
106 Darvishi V, Darvishi S, Bahrami-Bavani M, Navidbakhsh M, Asiaei S. Centrifugal isolation of SARS-CoV-2: numerical simulation for purification of hospitals' air. Biomech Model Mechanobiol 2021. [PMID: 34138382 DOI: 10.1007/s10237-021-01477-x] [Reference Citation Analysis]
107 Riva L, Yuan S, Yin X, Martin-Sancho L, Matsunaga N, Pache L, Burgstaller-Muehlbacher S, De Jesus PD, Teriete P, Hull MV, Chang MW, Chan JF, Cao J, Poon VK, Herbert KM, Cheng K, Nguyen TH, Rubanov A, Pu Y, Nguyen C, Choi A, Rathnasinghe R, Schotsaert M, Miorin L, Dejosez M, Zwaka TP, Sit KY, Martinez-Sobrido L, Liu WC, White KM, Chapman ME, Lendy EK, Glynne RJ, Albrecht R, Ruppin E, Mesecar AD, Johnson JR, Benner C, Sun R, Schultz PG, Su AI, García-Sastre A, Chatterjee AK, Yuen KY, Chanda SK. Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing. Nature 2020;586:113-9. [PMID: 32707573 DOI: 10.1038/s41586-020-2577-1] [Cited by in Crossref: 264] [Cited by in F6Publishing: 252] [Article Influence: 132.0] [Reference Citation Analysis]
108 Kang CK, Shin HM, Choe PG, Park J, Hong J, Seo JS, Lee YH, Chang E, Kim NJ, Kim M, Kim YW, Kim HR, Lee CH, Seo JY, Park WB, Oh MD. Broad humoral and cellular immunity elicited by one-dose mRNA vaccination 18 months after SARS-CoV-2 infection. BMC Med 2022;20:181. [PMID: 35508998 DOI: 10.1186/s12916-022-02383-4] [Reference Citation Analysis]